539287 Stock Overview
Ortin Laboratories Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Ortin Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹19.43 |
| 52 Week High | ₹30.33 |
| 52 Week Low | ₹16.15 |
| Beta | 1.27 |
| 1 Month Change | 7.88% |
| 3 Month Change | -7.17% |
| 1 Year Change | 0.67% |
| 3 Year Change | -38.90% |
| 5 Year Change | -33.38% |
| Change since IPO | -36.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539287 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -11.1% | -2.5% | -2.5% |
| 1Y | 0.7% | 55.2% | 44.5% |
Return vs Industry: 539287 underperformed the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 539287 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 539287 volatility | |
|---|---|
| 539287 Average Weekly Movement | 6.9% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 539287 has not had significant price volatility in the past 3 months.
Volatility Over Time: 539287's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 24 | Sanka Murali Murthy | www.ortinlabsindia.com |
Ortin Laboratories Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti-diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti-anginal and cardio vascular, and antifungal products.
Ortin Laboratories Limited Fundamentals Summary
| 539287 fundamental statistics | |
|---|---|
| Market cap | ₹157.99m |
| Earnings (TTM) | -₹41.00m |
| Revenue (TTM) | ₹34.23m |
4.6x
P/S Ratio-3.9x
P/E RatioIs 539287 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539287 income statement (TTM) | |
|---|---|
| Revenue | ₹34.23m |
| Cost of Revenue | ₹45.58m |
| Gross Profit | -₹11.34m |
| Other Expenses | ₹29.65m |
| Earnings | -₹41.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.04 |
| Gross Margin | -33.14% |
| Net Profit Margin | -119.76% |
| Debt/Equity Ratio | 61.6% |
How did 539287 perform over the long term?
See historical performance and comparison